Oracle Corporation et al v. Druglogic, Inc.
Filing
97
STIPULATION AND ORDER GRANTING ORACLE LEAVE TO AMEND ITS ANSWER AND DEFENSES. Signed by Judge Joseph C. Spero on 12/12/11. (klhS, COURT STAFF) (Filed on 12/12/2011)
Case3:11-cv-00910-JCS Document96
1
2
3
4
5
6
7
Filed12/09/11 Page1 of 2
KAREN JOHNSON-MCKEWAN (State Bar No. 121570)
kjohnson-mckewan@orrick.com
I. NEEL CHATTERJEE (State Bar No. 173985)
nchatterjee@orrick.com
MICHAEL C. SPILLNER (State Bar No. 205785)
mspillner@orrick.com
ORRICK, HERRINGTON & SUTCLIFFE LLP
1000 Marsh Road
Menlo Park, CA 94025
Telephone: (650) 614-7400
Fax: (650) 614-7401
Attorneys for Plaintiffs and Counterclaim Respondents
Oracle Corp., Oracle Int’l Corp., and Oracle America, Inc.
8
13
PETER J. DAVIS (Admitted pro hac vice)
pdavis@wtplaw.com
STEVEN E. TILLER (Admitted pro hac vice)
stiller@wtplaw.com
WHITEFORD, TAYLOR & PRESTON
Seven Saint Paul Street
Baltimore, MD 21202
Phone: 410-347-8738
Fax: 410-223-4304
14
Attorneys for Defendant and Counterclaimant
DrugLogic, Inc.
9
10
11
12
15
16
UNITED STATES DISTRICT COURT
17
NORTHERN DISTRICT OF CALIFORNIA
18
19
20
21
22
ORACLE CORPORATION and ORACLE
INTERNATIONAL CORPORATION,
Plaintiffs,
v.
DRUGLOGIC, INC.,
Defendant.
23
24
25
26
27
Counterclaimant,
v.
ORACLE CORPORATION, ORACLE
INTERNATIONAL CORPORATION, and
ORACLE AMERICA, INC.,
Counterclaim Defendants.
OHSWEST:261415888.1
STIPULATION AND [PROPOSED]
ORDER GRANTING ORACLE
LEAVE TO AMEND ITS ANSWER
AND DEFENSES
The Honorable Joseph C. Spero
DRUGLOGIC, INC.,
28
Case No. 11-cv-00910 JCS
Case3:11-cv-00910-JCS Document96
Filed12/09/11 Page2 of 2
1
The parties jointly request that Plaintiffs and Counterclaim Defendants Oracle
2
Corporation, Oracle International Corporation, and Oracle America Inc. (“Oracle”) be granted
3
leave to amend their “Answer and Defenses to DrugLogic, Inc.’s Second Amended
4
Counterclaims” (“Answer and Defenses”). Oracle filed its Answer and Defenses on November
5
30, 2011. The parties believe that an amendment will promote judicial economy by potentially
6
avoiding motion practice relating to the sufficiency of Oracle’s pleading. The amendment will
7
not affect the Court’s schedule. Accordingly, the parties, by and through their counsel of record,
8
hereby stipulate and agree that:
9
1.
Oracle may amend its Answer and Defenses by December 19, 2011.
10
11
STIPULATED AND AGREED:
12
Dated: December 9, 2011
13
MICHAEL C. SPILLNER
ORRICK, HERRINGTON
& SUTCLIFFE LLP
17
18
19
Concurrence in the filing of this document has been obtained pursuant to General Order 45.
PURSUANT TO STIPULATION, IT IS SO ORDERED.
22
UNIT
ED
23
NO
Dated: 12/12/11
ISTRIC
ES D
TC
AT
T
JOSEPH C. SPERO
United States Magistrate Judge
RT
ER
25
26
27
28
OHSWEST:261415888.1
Spero
A
H
24
seph C.
Judge Jo
LI
21
RT
U
O
20
/s/ Steven E. Tiller /s/
Steven E. Tiller
Attorneys for DrugLogic, Inc.
R NIA
16
/s/ Michael C. Spillner /s/
Michael C. Spillner
Attorneys for Oracle Corp., Oracle Int’l
Corp., and Oracle America, Inc.
FO
15
S
14
STEVEN E. TILLER
WHITEFORD, TAYLOR & PRESTON
N
F
D IS T IC T O
R
C
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?